These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 22039016

  • 1. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
    Tajima M, Wakita D, Satoh T, Kitamura H, Nishimura T.
    Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
    [Abstract] [Full Text] [Related]

  • 2. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M, Heink S, Grothe H, Guralnik A, Reinhard K, Elflein K, Hünig T, Mittrücker HW, Brüstle A, Kamradt T, Lohoff M.
    Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
    [Abstract] [Full Text] [Related]

  • 3. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
    Faghih Z, Rezaeifard S, Safaei A, Ghaderi A, Erfani N.
    Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
    [Abstract] [Full Text] [Related]

  • 4. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients.
    Kuang DM, Peng C, Zhao Q, Wu Y, Zhu LY, Wang J, Yin XY, Li L, Zheng L.
    J Immunol; 2010 Aug 01; 185(3):1544-9. PubMed ID: 20581151
    [Abstract] [Full Text] [Related]

  • 5. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
    Vinay DS, Kwon BS.
    Cell Immunol; 1999 Feb 25; 192(1):63-71. PubMed ID: 10066348
    [Abstract] [Full Text] [Related]

  • 6. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
    Ye Z, Tang C, Xu S, Zhang B, Zhang X, Moyana T, Yang J, Xiang J.
    Cell Mol Immunol; 2007 Aug 25; 4(4):277-85. PubMed ID: 17764618
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases.
    Dobrzanski MJ, Reome JB, Dutton RW.
    J Immunol; 1999 Jun 01; 162(11):6671-80. PubMed ID: 10352285
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.
    Rodolfo M, Zilocchi C, Accornero P, Cappetti B, Arioli I, Colombo MP.
    J Immunol; 1999 Aug 15; 163(4):1923-8. PubMed ID: 10438927
    [Abstract] [Full Text] [Related]

  • 15. SUMO2 overexpression enhances the generation and function of interleukin-17-producing CD8⁺ T cells in mice.
    Won TJ, Lee YJ, Hyung KE, Yang E, Sohn UD, Min HY, Lee DI, Park SY, Hwang KW.
    Cell Signal; 2015 Jun 15; 27(6):1246-52. PubMed ID: 25762490
    [Abstract] [Full Text] [Related]

  • 16. A T(h)17-polarized cell population that has infiltrated the lung requires cells that convert to IFN-{gamma} production in order to induce airway hyperresponsiveness.
    Ashino S, Wakita D, Shiohama Y, Iwakura Y, Chamoto K, Ohkuri T, Kitamura H, Nishimura T.
    Int Immunol; 2010 Jun 15; 22(6):503-13. PubMed ID: 20501609
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity.
    Kosaka A, Wakita D, Matsubara N, Togashi Y, Nishimura S, Kitamura H, Nishimura T.
    Int Immunol; 2007 Mar 15; 19(3):249-56. PubMed ID: 17229818
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.